DISPOSITION OF L-CARNITINE AND ACETYL-L-CARNITINE IN THE ISOLATED-PERFUSED RAT-KIDNEY

被引:0
作者
MANCINELLI, A [1 ]
LONGO, A [1 ]
SHANAHAN, K [1 ]
EVANS, AM [1 ]
机构
[1] SIGMA TAU PHARMACEUT CO, ROME, ITALY
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The isolated perfused rat kidney was used to investigate the regulation, specificity and concentration-dependence of the renal tubular disposition of L-carnitine (LC) and its ester, acetyl-L-carnitine (ALC). Tritiated markers were used to study the renal disposition of LC and ALC and HPLC was used to purify H-3-LC and H-3-ALC before radiochemical analysis. At perfusate concentrations comparable to those found in plasma in vivo (50 mu M for LC and 5 mu M for ALC), the renal clearance of both analogues was substantially less than GFR (P < .05) which, in view of their negligible binding to perfusate proteins, is indicative of extensive reabsorption. During the first 20 min of perfusion, the percent tubular reabsorption (%TR) of LC and ALC was 94 +/- (SD) 2.6% and 97 +/- 0.6%, respectively. The extent of H-3-ALC and H-3-LC enrichment of perfusate in experiments with H-3-LC and H-3-ALC, respectively, provided evidence for the capability of the rat kidney to acetylate LC and deacetylate ALC. In addition, a portion of renally generated H-3-ALC and H-3-LC was found to undergo leakage into renal tubules and escape subsequent reabsorption. It was also found that the %TR of both compounds decreased substantially when the perfusate concentration was increased above endogenous levels; each compound was capable of decreasing the %TR of the other; and trimethylamine-N-oxide, a metabolite of LC, had no significant effect on the renal handling of the carnitine derivatives.
引用
收藏
页码:1122 / 1128
页数:7
相关论文
共 25 条
[1]   THE PHARMACOLOGY OF CARNITINE [J].
BAHL, JJ ;
BRESSLER, R .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1987, 27 :257-277
[2]   CARNITINE [J].
BIEBER, LL .
ANNUAL REVIEW OF BIOCHEMISTRY, 1988, 57 :261-283
[3]  
BRASS EP, 1978, J BIOL CHEM, V253, P2688
[4]   ACTION OF ACETYL-L-CARNITINE IN NEURODEGENERATION AND ALZHEIMERS-DISEASE [J].
CALVANI, M ;
CARTA, A ;
CARUSO, G ;
BENEDETTI, N ;
IANNUCCELLI, M .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1992, 663 :483-486
[5]   COMPARISON OF THE EFFECTS OF PARATHYROID-HORMONE (PTH) AND RECOMBINANT PTH-RELATED PROTEIN ON BICARBONATE EXCRETION BY THE ISOLATED PERFUSED RAT-KIDNEY [J].
ELLIS, AG ;
ADAM, WR ;
MARTIN, TJ .
JOURNAL OF ENDOCRINOLOGY, 1990, 126 (03) :403-408
[6]   PRIMARY SYSTEMIC CARNITINE DEFICIENCY .2. RENAL HANDLING OF CARNITINE [J].
ENGEL, AG ;
REBOUCHE, CJ ;
WILSON, DM ;
GLASGOW, AM ;
ROMSHE, CA ;
CRUSE, RP .
NEUROLOGY, 1981, 31 (07) :819-825
[8]   ABSORPTION OF D-CARNITINE AND L-CARNITINE BY THE INTESTINE AND KIDNEY TUBULE IN THE RAT [J].
GROSS, CJ ;
HENDERSON, LM .
BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 772 (02) :209-219
[9]   PHARMACOKINETICS OF BOLUS INTRAVENOUS AND ORAL DOSES OF L-CARNITINE IN HEALTHY-SUBJECTS [J].
HARPER, P ;
ELWIN, CE ;
CEDERBLAD, G .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 35 (01) :69-75
[10]   METABOLISM AND EXCRETION OF CARNITINE AND ACYLCARNITINES IN THE PERFUSED RAT-KIDNEY [J].
HOKLAND, BM ;
BREMER, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 886 (02) :223-230